3 articles, transcripts, and reports
The oncology research space has become rather crowded these days, with numerous clinical-level companies cropping up with novel technologies. While these offer a lot of…
Karyopharm Therapeutics Inc. (NASDAQ: KPTI) Q2 2020 earnings call dated Aug. 04, 2020 Corporate Participants: Ian Karp — Vice President, Investor and Public Relations Michael G. Kauffman — Chief…
Karyopharm Therapeutics Inc (KPTI) Q1 2020 earnings call dated May 05, 2020 Corporate Participants: Ian Karp — Vice President, Investor and Public Relations Michael G. Kauffman — Chief Executive…
